146 related articles for article (PubMed ID: 22224596)
1. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients.
Lee AI; Campigotto F; Rawn JD; Neuberg D; Kaufman RM; Berliner N
Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596
[No Abstract] [Full Text] [Related]
2. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
Silver DA; D'Ambra MN
Crit Care Med; 2007 Jul; 35(7):1782-3. PubMed ID: 17581365
[No Abstract] [Full Text] [Related]
3. The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery.
Wasowicz M; Meineri M; McCluskey SM; Mitsakakis N; Karkouti K
J Cardiothorac Vasc Anesth; 2009 Dec; 23(6):828-34. PubMed ID: 19467888
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
Lamarche Y; Demers P; Poirier NC; Robitaille D; Cartier R
Can J Cardiol; 2007 Aug; 23(10):809-13. PubMed ID: 17703260
[TBL] [Abstract][Full Text] [Related]
5. Fatal thrombotic event after infusion of recombinant activated factor VII after cardiac surgery.
Pichon N; Bellec F; Sekkal S; Marsaud JP; Laskar M; François B; Vignon P
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):220-1. PubMed ID: 18603082
[No Abstract] [Full Text] [Related]
6. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
7. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
[No Abstract] [Full Text] [Related]
8. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
9. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
[TBL] [Abstract][Full Text] [Related]
10. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.
Tanaka KA; Mazzeffi MA; Grube M; Ogawa S; Chen EP
Transfusion; 2013 Apr; 53(4):920-1. PubMed ID: 23565996
[No Abstract] [Full Text] [Related]
11. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
12. eComment. Recombinant activated factor VII in pediatric cardiac surgery: possibilities and limitations.
Bockeria LA; Kupryashov AA; Samsonova NN
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):694-5. PubMed ID: 22991396
[No Abstract] [Full Text] [Related]
13. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Chapman AJ; Blount AL; Davis AT; Hooker RL
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
[TBL] [Abstract][Full Text] [Related]
15. Management of severe sphincterotomy bleeding with recombinant activated factor VII.
Garrido-Serrano A
Gastrointest Endosc; 2012 Oct; 76(4):925-6. PubMed ID: 22985655
[No Abstract] [Full Text] [Related]
16. Factor VII for excessive bleeding following congenital heart disease surgery.
Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
[TBL] [Abstract][Full Text] [Related]
17. Haemostatic management in high-risk cardiac surgery: a role of recombinant factor VIIa (NovoSeven RT).
Petricevic M; Biocina B; Konosic S; Burcar I
Eur J Cardiothorac Surg; 2012 Sep; 42(3):606-7. PubMed ID: 22504897
[No Abstract] [Full Text] [Related]
18. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
[No Abstract] [Full Text] [Related]
19. Successful use of factor VIIa to control life-threatening post-operative haemorrhage in a patient on extra-corporeal membrane oxygenation.
Dunne B; Xiao P; Andrews D
Heart Lung Circ; 2012 Apr; 21(4):229-30. PubMed ID: 22036715
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
